UNSPSC 85815725: Introduction of low-dose interleukin-2 into central vein, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of low-dose interleukin-2 into central vein, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E04303

UNSPSC 85815725 (Introduction of low-dose interleukin-2 into central vein, percutaneous approach), a Commodity code, does not align with state and local government procurement activity. The source lists 40 recent opportunities tagged to this code, but none involve the clinical procedure named in the code description. Instead, the opportunities span virtual urgent care services, medical services, occupational health, behavioral health, wellness platforms, EMS staffing, cancer screening, mental health treatment, substance use disorder recovery, and inmate health—domains orthogonal to invasive immunotherapy administration.

The code shows little relevant recent activity. When state and local procurement offices tag opportunities under this Commodity, the mismatch suggests either systematic taxonomy misapplication or a data-integration error in the upstream categorization system. For business development purposes, treat this code as a signal of tagging inconsistency rather than a meaningful market segment. Pursue opportunities only after confirming the actual scope of work with the issuing body directly; do not rely on the code number alone to predict procurement intent or scope alignment.